Patents Assigned to NeuroVasc Technologies, Inc
-
Patent number: 12059163Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: GrantFiled: October 25, 2020Date of Patent: August 13, 2024Assignee: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Patent number: 11871947Abstract: A clot removal device has a segment that has two main struts that serve as a frame for holding a plurality of secondary struts. Each of the two main struts has a proximal end that is connected at a proximal point of the segment and extends along a generally circumferential path, with each main strut terminating at a separate connecting point that is distal from the proximal point. The connecting points are connected to each other to form a generally tubular structure defining an inner lumen. The plurality of secondary struts forms a lattice of cells, with each cell surrounded by four secondary struts. Two generally straight distal struts are connected to the lattice of cells at a distal end of the segment, and are connected to each other to form a distal point. A distal opening is defined by the cells adjacent the distal struts, the distal opening communicating with the lumen and terminating at the proximal point.Type: GrantFiled: July 30, 2020Date of Patent: January 16, 2024Assignee: NeuroVasc Technologies, Inc.Inventors: Michael Losordo, Jianlu Ma
-
Publication number: 20230027756Abstract: A clot removal device has a segment that has two main struts that serve as a frame for holding a plurality of secondary struts. Each of the two main struts has a proximal end that is connected at a proximal point of the segment and extends along a generally circumferential path, with each main strut terminating at a separate connecting point that is distal from the proximal point. The connecting points are connected to each other to form a generally tubular structure defining an inner lumen. The plurality of secondary struts forms a lattice of cells, with each cell surrounded by four secondary struts. Two generally straight distal struts are connected to the lattice of cells at a distal end of the segment, and are connected to each other to form a distal point.Type: ApplicationFiled: September 30, 2022Publication date: January 26, 2023Applicant: NeuroVasc Technologies, Inc.Inventors: Michael Losordo, Jianlu Ma
-
Publication number: 20220022901Abstract: A clot removal device has an expandable treatment member, a proximal section, and a transition section having a distal end connected to the proximal end of the expandable treatment member, and a proximal end connected to the distal end of the proximal section. A delivery wire has a distal end coupled to the proximal section. The diameter of the proximal section is smaller than the diameter of the expandable treatment member, and the transition section has a diameter that varies from its proximal end to its distal end.Type: ApplicationFiled: October 7, 2021Publication date: January 27, 2022Applicant: NeuroVasc Technologies, Inc.Inventors: Hyung Phouasalit, Michael Losordo
-
Publication number: 20220000503Abstract: The present invention provides devices for removing an embolus or thrombus. The device includes an elongate member configured for insertion into the vasculature, an expandable member that extends from the distal end of the elongate member, and a flow restrictor associated with a proximal portion of the expandable member. The expandable member is configured to transition from a compacted state to an expanded state, in which the expandable portion engages with the embolus. The flow restrictor is configured to restrict blood flow and generate a low pressure zone at a location in the vasculature that is distal to the flow restrictor.Type: ApplicationFiled: September 14, 2021Publication date: January 6, 2022Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Patent number: 11123089Abstract: The present invention provides devices for removing an embolus or thrombus. The device includes an elongate member configured for insertion into the vasculature, an expandable member that extends from the distal end of the elongate member, and a flow restrictor associated with a proximal portion of the expandable member. The expandable member is configured to transition from a compacted state to an expanded state, in which the expandable portion engages with the embolus. The flow restrictor is configured to restrict blood flow and generate a low pressure zone at a location in the vasculature that is distal to the flow restrictor.Type: GrantFiled: January 25, 2017Date of Patent: September 21, 2021Assignee: NeuroVasc Technologies, IncInventor: Jianlu Ma
-
Publication number: 20210038236Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: ApplicationFiled: October 25, 2020Publication date: February 11, 2021Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Patent number: 10835271Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: GrantFiled: September 6, 2018Date of Patent: November 17, 2020Assignee: NeuroVasc Technologies Inc.Inventor: Jianlu Ma
-
Publication number: 20200352585Abstract: A clot removal device has a segment that has two main struts that serve as a frame for holding a plurality of secondary struts. Each of the two main struts has a proximal end that is connected at a proximal point of the segment and extends along a generally circumferential path, with each main strut terminating at a separate connecting point that is distal from the proximal point. The connecting points are connected to each other to form a generally tubular structure defining an inner lumen. The plurality of secondary struts forms a lattice of cells, with each cell surrounded by four secondary struts. Two generally straight distal struts are connected to the lattice of cells at a distal end of the segment, and are connected to each other to form a distal point. A distal opening is defined by the cells adjacent the distal struts, the distal opening communicating with the lumen and terminating at the proximal point.Type: ApplicationFiled: July 30, 2020Publication date: November 12, 2020Applicant: NeuroVasc Technologies, Inc.Inventors: Michael Losordo, Jianlu Ma
-
Publication number: 20190274810Abstract: A clot removal device has an expandable treatment member, a proximal section, and a transition section having a distal end connected to the proximal end of the expandable treatment member, and a proximal end connected to the distal end of the proximal section. A delivery wire has a distal end coupled to the proximal section. The diameter of the proximal section is smaller than the diameter of the expandable treatment member, and the transition section has a diameter that varies from its proximal end to its distal end.Type: ApplicationFiled: March 12, 2019Publication date: September 12, 2019Applicant: NeuroVasc Technologies, Inc.Inventors: Hyung Phouasalit, Michael Losordo
-
Publication number: 20190000490Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: ApplicationFiled: September 6, 2018Publication date: January 3, 2019Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Publication number: 20180344337Abstract: A clot removal device has a segment that has two main struts that serve as a frame for holding a plurality of secondary struts. Each of the two main struts has a proximal end that is connected at a proximal point of the segment and extends along a generally circumferential path, with each main strut terminating at a separate connecting point that is distal from the proximal point. The connecting points are connected to each other to form a generally tubular structure defining an inner lumen. The plurality of secondary struts forms a lattice of cells, with each cell surrounded by four secondary struts. Two generally straight distal struts are connected to the lattice of cells at a distal end of the segment, and are connected to each other to form a distal point. A distal opening is defined by the cells adjacent the distal struts, the distal opening communicating with the lumen and terminating at the proximal point.Type: ApplicationFiled: May 29, 2018Publication date: December 6, 2018Applicant: NeuroVasc Technologies, Inc.Inventors: Michael Losordo, Jianlu Ma
-
Patent number: 10070878Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: GrantFiled: February 15, 2017Date of Patent: September 11, 2018Assignee: NeuroVasc Technologies Inc.Inventor: Jianlu Ma
-
Publication number: 20180103969Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: ApplicationFiled: February 15, 2017Publication date: April 19, 2018Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Publication number: 20180064454Abstract: A clot removal device has a segment that has two main struts that serve as a frame for holding a plurality of secondary struts. Each of the two main struts has a proximal end that is connected at a proximal point of the segment and extends along a generally circumferential path, with each main strut terminating at a separate connecting point that is distal from the proximal point. The connecting points are connected to each other to form a generally tubular structure defining an inner lumen. The plurality of secondary struts forms a lattice of cells, with each cell surrounded by four secondary struts. Two generally straight distal struts are connected to the lattice of cells at a distal end of the segment, and are connected to each other to form a distal point. A distal opening is defined by the cells adjacent the distal struts, the distal opening communicating with the lumen and terminating at the proximal point.Type: ApplicationFiled: June 5, 2017Publication date: March 8, 2018Applicant: NeuroVasc Technologies, Inc.Inventors: Michael Losordo, Jianlu Ma
-
Publication number: 20170128089Abstract: The present invention provides devices for removing an embolus or thrombus. The device includes an elongate member configured for insertion into the vasculature, an expandable member that extends from the distal end of the elongate member, and a flow restrictor associated with a proximal portion of the expandable member. The expandable member is configured to transition from a compacted state to an expanded state, in which the expandable portion engages with the embolus. The flow restrictor is configured to restrict blood flow and generate a low pressure zone at a location in the vasculature that is distal to the flow restrictor.Type: ApplicationFiled: January 25, 2017Publication date: May 11, 2017Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Publication number: 20170119408Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: ApplicationFiled: October 15, 2016Publication date: May 4, 2017Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Publication number: 20170119409Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.Type: ApplicationFiled: October 15, 2016Publication date: May 4, 2017Applicant: NeuroVasc Technologies, Inc.Inventor: Jianlu Ma
-
Patent number: 9585741Abstract: The present invention provides devices for removing an embolus or thrombus. The device includes an elongate member configured for insertion into the vasculature, an expandable member that extends from the distal end of the elongate member, and a flow restrictor associated with a proximal portion of the expandable member. The expandable member is configured to transition from a compacted state to an expanded state, in which the expandable portion engages with the embolus. The flow restrictor is configured to restrict blood flow and generate a low pressure zone at a location in the vasculature that is distal to the flow restrictor.Type: GrantFiled: January 16, 2015Date of Patent: March 7, 2017Assignee: NeuroVasc Technologies, IncInventor: Jianlu Ma